The aim of establishing a biological collection associated with the existing rare cerebral vascular disease cohort is to identify new prognostic or disease progression biomarkers that could improve patient care or identify new therapeutic targets.
Study Type
OBSERVATIONAL
Enrollment
500
Blood and urine sampling
Lariboisière hospital
Paris, France
Time required for sample storage (freezing) to ensure the stability of most measurable elements in a biological sample
for each sample
Time frame: Up to 2 years after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.